Opinion|Videos|October 3, 2024
Tips for Integrating Photodynamic Therapy in the Clinic
Author(s)Brad Glick, DO, MPH
Brad Glick, DO, MPH, discusses how to effectively introduce photodynamic therapy (PDT) into a dermatology clinic by outlining necessary equipment and setup, providing guidance on essential patient discussions for treatment introduction, and sharing strategies to ensure treatment efficacy while prioritizing patient safety and satisfaction.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What steps should be taken to introduce PDT into a dermatology clinic and what equipment setup is needed?
- For clinicians new to using PDT in their clinics, what discussion is needed with patients to introduce the treatment to them?
- How do you specifically incorporate PDT to achieve treatment efficacy while still maintaining patient satisfaction and safety?
Advertisement
Related to this article
Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
Updated SKYRIZI labeling allows clinicians to use clinical judgment when determining the need for TB evaluation before treatment.
Experts outline how to recognize undertreated psoriasis, assess incomplete response, and make individualized decisions when escalating therapy.
ATI-052 improved disease severity and itch in a phase 1b trial of patients with severe atopic dermatitis, with no grade 3 or 4 adverse events.
LRM will evaluate injectable rhPDGF-BB as a regenerative approach to infraorbital hollowing in a randomized phase 2b trial.
ORKA-001 achieved PASI 100 in 61% of high-dose patients at week 16 in the phase 2b EVERLAST-B trial of moderate-to-severe psoriasis.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Stratman discusses individualized eczema care, expanding treatment options, and the potential of precision medicine to guide therapy.
Advertisement
Advertisement
Trending on Dermatology Times
1
How Approvals, Setbacks, and a Crowded Pipeline Are Reshaping the AD Treatment Landscape
2
ATI-052 Shows Rapid Improvements in Atopic Dermatitis
3
ORKA-001 Achieves 61% Complete Skin Clearance in Psoriasis
4
FDA Revises TB Evaluation Guidance for SKYRIZI
5